tiprankstipranks
Leadership Changes and Stockholder Decisions at TScan Therapeutics
PremiumCompany AnnouncementsLeadership Changes and Stockholder Decisions at TScan Therapeutics
5M ago
TScan Therapeutics appoints Nicholson to board of directors, Biggar as Chair
Premium
The Fly
TScan Therapeutics appoints Nicholson to board of directors, Biggar as Chair
5M ago
TScan Therapeutics receives FDA’s RMAT designation for two TCR-T candidates
Premium
The Fly
TScan Therapeutics receives FDA’s RMAT designation for two TCR-T candidates
6M ago
TScan announces first patient dosed in Phase 1 trial of TCR-T therapy
PremiumThe FlyTScan announces first patient dosed in Phase 1 trial of TCR-T therapy
7M ago
TScan Therapeutics 2.473M share Spot Secondary priced at $7.13
Premium
The Fly
TScan Therapeutics 2.473M share Spot Secondary priced at $7.13
7M ago
TScan Therapeutics Advances in Solid and Hematological Cancer Therapy
Premium
Company Announcements
TScan Therapeutics Advances in Solid and Hematological Cancer Therapy
7M ago
TScan Therapeutics reports Q4 EPS (21c), consensus (29c)
PremiumThe FlyTScan Therapeutics reports Q4 EPS (21c), consensus (29c)
9M ago
Tscan Therapeutics, Inc. (TCRX) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Tscan Therapeutics, Inc. (TCRX) Q4 Earnings Cheat Sheet
9M ago
TScan Therapeutics presents Phase 1 clinical results on TSC-100, TSC-101
Premium
The Fly
TScan Therapeutics presents Phase 1 clinical results on TSC-100, TSC-101
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100